Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Question for Dan Carlson of Tailwinds
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(64)
•••
Comment by TheTruth1234on Aug 26, 2023 12:26pm
187 Views
Post# 35606734

RE:RE:RE:RE:Question for Dan Carlson of Tailwinds

RE:RE:RE:RE:Question for Dan Carlson of Tailwinds
Boomskid wrote: I never kept a record of buying, holding and selling that I influenced, TT-Boy.

What I do know is that you and some others accuse me of being so effective that I made victims of you.

That means that you agree that I was VERY effective, so effective that you blame me for your losses.

Look, we know you're angry and not thinking straight. 

Just don't make it so obvious.

So what was I? Effective? Not Effective? Make up your mind and stick with it.

I'm not laughing at you. You're falling apart. Get a grip.

jd



Look, we know you're angry and not thinking straight

Angry?

Far from it Johnny boy!

I am actually out the door to finalize payment for the new hot tub I bought.  Cost about $11000!!

Cant wait for Monday delivery and set up!!


How about you Johnny boy? 

What are doing today, other than counting the hours for your social assistance cheque arrive, so you can buy food.


How could this happen to the smartest man in the room, who was the only one who could connect the dots?
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities